159 related articles for article (PubMed ID: 16315870)
1. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Kondo H; Yamamoto K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
Yoshino S; Yoshida S; Maeda N; Maeda Y; Maeda K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2798-800. PubMed ID: 21224717
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
5. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
6. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
7. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
[TBL] [Abstract][Full Text] [Related]
8. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
[TBL] [Abstract][Full Text] [Related]
10. [Adhesion therapy for malignant pleural effusion (intrapleural administration of OK-432 with minocycline)].
Tanaka A; Sato T
Nihon Kokyuki Gakkai Zasshi; 1999 Jul; 37(7):531-7. PubMed ID: 10481458
[TBL] [Abstract][Full Text] [Related]
11. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
[TBL] [Abstract][Full Text] [Related]
12. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
Kan N
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
[TBL] [Abstract][Full Text] [Related]
13. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
14. [Immunochemotherapy of carcinomatous peritonitis and pleuritis--report of 2 cases].
Takekoshi H; Yoshida K; Morinaga S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1466-9. PubMed ID: 1326910
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
[TBL] [Abstract][Full Text] [Related]
16. [Administration of docetaxel in cases of recurrent breast carcinoma with malignant pleural effusion controlled by intrapleural administration of OK-432].
Kikumori T; Hayashi H; Shibata A; Sekiya M; Itoh T; Mase T; Oiwa M; Imai T; Funahashi H
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2091-4. PubMed ID: 10584578
[TBL] [Abstract][Full Text] [Related]
17. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis].
Yoshino S; Oka M; Hazama S; Suzuki T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1588-91. PubMed ID: 2389953
[TBL] [Abstract][Full Text] [Related]
18. Intracavitary injection of OK-432 for malignant pericardial effusion, a case report.
Nanjo T
Radiat Med; 1990; 8(4):155-8. PubMed ID: 2281151
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
